Government may buy 50 million Pfizer Covid vaccine doses by Q3
Published
The government and Pfizer are in “high-level” discussions that could see the pharma giant sell 50 million of its Covid vaccine doses in India by the third quarter of this year with the current negotiations pointing to a successful conclusion. Top government officials are believed to have negotiated availability of these vaccines in a series of meetings with senior Pfizer executives with the main hurdle being the firm’s insistence of indemnity that will shield it from legal action in India.
Full Article